Pay in 4 interest-free payments of $7.15 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Video visits and managed titration: MyStart Health
Free of most common allergens Our natural formula is free of common allergens such as dairy, gluten, wheat, soy, or yeast
Retatrutide Side Effects (Preliminary Data) Common (from Phase 2 data): Nausea (25-45% depending on dose) Diarrhea (20-35%) Vomiting (10-20%) Constipation (10-15%) Decreased appetite Notable differences: Mild increases in resting heart rate observed The glucagon receptor component may introduce metabolic effects not seen with GLP-1-only medications Full safety profile awaiting Phase 3 data The overall tolerability of retatrutide in the Phase 2 trial was described as acceptable, with most adverse events being mild to moderate
Tirzepatide reduces inflammation primarily through weight loss, and this effect could be beneficial in overweight, obese individuals and those with metabolic dysfunction (Sattar et al
The GLP-1 portion is 90 percent homologous to native human GLP-1, with structural changes at the site where the enzyme DPP-4 would normally cut it
It improves insulin sensitivity, reduces glucose production in the liver, and promotes metabolic health
US$ 23.07
US$ 21.89
US$ 22.60
US$ 28.65
